Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase

Autor: Nicole Grandi, Enzo Tramontano, Francesca Esposito, Davide Ialongo, Alessandro De Leo, Giorgio Amendola, Daniela De Vita, Antonella Messore, Valentina Noemi Madia, Marie-Line Andreola, Ettore Novellino, Mathieu Métifiot, Sandro Cosconati, Roberta Costi, Angela Corona, Roberto Di Santo, Valeria Tudino, Francesco Saccoliti, Luigi Scipione
Přispěvatelé: Microbiologie Fondamentale et Pathogénicité [Bordeaux] (MFP), Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS), Messore, A., Corona, A., Madia, V. N., Saccoliti, F., Tudino, V., De Leo, A., Ialongo, D., Scipione, L., De Vita, D., Amendola, G., Novellino, E., Cosconati, S., Metifiot, M., Andreola, M. -L., Esposito, F., Grandi, N., Tramontano, E., Costi, R., Di Santo, R.
Rok vydání: 2021
Předmět:
Quinolone
Anti-HIV Agents
Microbial Sensitivity Tests
Quinolones
HeLa Cell
Virus Replication
01 natural sciences
Article
03 medical and health sciences
Drug Discovery
Humans
Ribonuclease H
Human Immunodeficiency Viru

Magnesium
AIDS
HIV
rNase H inhibitors
Quinolinonyl non-diketo acid derivatives
RNase H
ComputingMilieux_MISCELLANEOUS
Polymerase
030304 developmental biology
chemistry.chemical_classification
0303 health sciences
biology
Microbial Sensitivity Test
[CHIM.ORGA]Chemical Sciences/Organic chemistry
Chemistry
Anti-HIV Agent
Reverse transcriptase
Reverse Transcriptase Inhibitor
3. Good health
0104 chemical sciences
Amino acid
Integrase
Molecular Docking Simulation
010404 medicinal & biomolecular chemistry
Ribonuclease H
Human Immunodeficiency Virus

Enzyme
Biochemistry
Viral replication
Docking (molecular)
Mutation
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
HIV-1
Mutagenesis
Site-Directed

biology.protein
Reverse Transcriptase Inhibitors
Molecular Medicine
Human
HeLa Cells
Protein Binding
Zdroj: Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, American Chemical Society, 2021, 64 (12), pp.8579-8598. ⟨10.1021/acs.jmedchem.1c00535⟩
ISSN: 1520-4804
0022-2623
DOI: 10.1021/acs.jmedchem.1c00535
Popis: Novel anti-HIV agents are still needed to overcome resistance issues, in particular inhibitors acting against novel viral targets. The ribonuclease H (RNase H) function of the reverse transcriptase (RT) represents a validated and promising target, and no inhibitor has reached the clinical pipeline yet. Here, we present rationally designed non-diketo acid selective RNase H inhibitors (RHIs) based on the quinolinone scaffold starting from former dual integrase (IN)/RNase H quinolinonyl diketo acids. Several derivatives were synthesized and tested against RNase H and viral replication and found active at micromolar concentrations. Docking studies within the RNase H catalytic site, coupled with site-directed mutagenesis, and Mg2+ titration experiments demonstrated that our compounds coordinate the Mg2+ cofactor and interact with amino acids of the RNase H domain that are highly conserved among naïve and treatment-experienced patients. In general, the new inhibitors influenced also the polymerase activity of RT but were selective against RNase H vs the IN enzyme.
Databáze: OpenAIRE